Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts -- more

Lilly Announces Completion of Hypnion Acquisition -- more

Illumina Announces the Completion of Its Acquisition of Solexa -- more

Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals' Nicotinic Alpha-7 Agonist, MEM 3454 -- more

Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma -- more

Dynogen to Present Positive Clinical Data For DDP225 And DDP733 At Digestive -- more

Elixir Pharmaceuticals Announces Issuance of SIRT Patent Covering Development of New Therapies Based on Breakthrough Science -- more

Trubion Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Rheumatoid Arthritis -- more

Santhera Shareholders Approve all Board Proposals at Annual Shareholders' Meeting -- more

BrainCells Inc. Expands Series B Financing to $50 Million -- more

Xanthus’ Symadex Reverses Disease in Preclinical Mouse Models of Multiple Sclerosis -- more

Pathway Medical Technologies, Inc. Secures $24.5 Million Financing -- more

Xanthus Presents Data Supporting Distinctive Mechanism of Action for Xanafide® -- more

Santhera Presents Clinical Efficacy Data of SNT-MC17 in DMD at the American Academy of Neurology Annual Meeting --
Archived News Items